Filtered By:
Countries: Australia Health
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 48132 results found since Jan 2013.
What to use instead of NICE Evidence Search - a first thought
I have been promoting NICE Evidence Search much more systematically this year to " my " first year undergraduates in their first library session. It is also on the resource lists I ' ve made for each of their courses. I like the idea that there is one source, where all the results have been evaluated by health information professionals, and I ' ve suggested it ' s a good first place to search for any health topic. But NICE Evidence Search is closing at the end of March 2022. So what to use instead?NICE Evidence Search has two lists of sources, one of sites where some of the content is...
Source: Browsing - February 9, 2022 Category: Databases & Libraries Tags: NICE Evidence Search Source Type: blogs
What to use instead of NICE Evidence Search - some recommendations (sort of)
In an earlier post I searched NICE Evidence Search (closing at the end of March 2022) and then a number of other sources to see which other sources would find the material.I found 27 results (vertigo epley was the search) in NICE Evidence Search. 5 were systematic reviews from DARE, which I decided I was not too worried about, as DARE has not been updated for some timeThen there were results from PubMed, Cochrane, BestBets, CKS, four health organisations, Patient.info, NICE and the Royal Australian College of GPs.SearchingCochraneitself found one more Cochrane review than NICE Evidence Search did. So, more...
Source: Browsing - March 10, 2022 Category: Databases & Libraries Tags: NICE Evidence Search Source Type: blogs
Non-randomized safety and performance evaluation of the av-Guardian vascular access system.
CONCLUSION: The results demonstrated the safety and feasibility of a subcutaneously implanted, extravascular device in achieving repeatable successful cannulation via a constant site, to facilitate blunt needling in matured arteriovenous fistula in limited number of patients.
PMID: 31920144 [PubMed - as supplied by publisher]
Source: The Journal of Vascular Access - January 11, 2020 Category: Surgery Tags: J Vasc Access Source Type: research
Global challenges with providing vascular access care during COVID era
CONCLUSIONS: The COVID19 pandemic is far from over, and the challenges and barriers to providing dialysis access care seen on the initial ASDIN survey in the US seem to extend across the globe. We describe those results and discuss options, opportunities, and innovative tools to provide dialysis and access care during these trying times.PMID:36203353 | DOI:10.1177/11297298221106853
Source: The Journal of Vascular Access - October 7, 2022 Category: Surgery Authors: Karthik Ramani Tushar J Vachharajani Edgar Lerma Anil K Agarwal Source Type: research
Terumo pays at least $20m for Medeon Biodesign ’ s XPro vascular closure device
Medeon Biodesign (TPEx:6499) said today that it agreed to sell its XPro suture-mediated vascular closure device to Terumo Corp. (TYO:4543) for $20 million up front, plus milestones.
The XPro device is designed for vascular closure following transcatheter aortic valve replacement, endovascular aneurysm repair, thoracic endovascular aneurysm repair and percutaneous balloon aortic valvuloplasty procedures. Medeon said it plans to continue working with Terumo on future technical, clinical and regulatory developments for the system.
In May 2017 Medeon won approval in New Zealand for a clinical trial of the XPro suture-mediat...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Vascular Wall Street Beat Medeon Biodesign Terumo Source Type: news
Vascular Surgery in Australia and New Zealand (Australasia)
The delivery of vascular surgical services can be challenging. Australia and New Zealand are not immune to many of the global issues facing the international vascular surgery community, especially in this era of a global pandemic. These include the increase in rates of diabetes and obesity, and an ageing population. The change of paradigm in treatment methods, training of vascular surgeons, and the usual limited financial budget to work with are some common themes.
Source: European Journal of Vascular and Endovascular Surgery - July 19, 2021 Category: Surgery Authors: Irwin V. Mohan, Manar Khashram, Robert Fitridge Tags: Editorial: Global Tour D'Horizon Source Type: research
Adherence to Guideline-Recommended Therapy Including Supervised Exercise Therapy Referral Across Peripheral Artery Disease Specialty Clinics: Insights From the International PORTRAIT Registry
Prospective study of the Patient-Centered Outcomes Related to Treatment Practice in Peripheral Vascular Disease: Investigating Trajectories (PORTRAIT) registry from 16 vascular specialty clinics (United States, 10; The Netherlands, 5; Australia, 1) between 2011 and 2015.
Source: Journal of Vascular Surgery - April 22, 2020 Category: Surgery Authors: J.T. Saxon, D.M. Safley, C. Mena-Hurtado, J. Heyligers, R. Fitridge, M. Shishehbor Tags: Vascular physicians do not do a good job referring patients with claudication for supervised exercise therapy Source Type: research
LEA 37. Mortality of Paclitaxel Patients in an Australian Vascular Surgical Center
A recent meta-analysis has suggested a significant dose-related increase in mortality after the use of paclitaxel-coated balloons in infrainguinal endovascular procedures. We aimed to review mortality outcomes of paclitaxel-naive and paclitaxel-treated (PT) infrainguinal peripheral artery disease patients treated by a single Australian vascular surgical unit.
Source: Journal of Vascular Surgery - October 21, 2019 Category: Surgery Authors: David Herlihy, Quoc Tran, Charles Fisher, Vikram Puttaswamy Source Type: research
Coil embolization for the treatment of peripheral veins:: A position statement of the International Union of Phlebology (UIP), the Australasian College of Phlebology (ACP), the Australia and New Zealand Society for Vascular Surgery (ANZSVS), the American Venous Forum (AVF), the American Vein and Lymphatic Society (AVLS), and the Interventional Radiology Society of Australia (IRSA)
Publication date: Available online 24 April 2020Source: Journal of Vascular Surgery: Venous and Lymphatic DisordersAuthor(s): Kurosh Parsi, Andrew Hill, Andrew Bradbury, Mark Meissner, Antonios Gasparis, Christopher Rogan, Andre van Rij
Source: Journal of Vascular Surgery: Venous and Lymphatic Disorders - April 28, 2020 Category: Surgery Source Type: research
Pulmonary arterial hypertension with below threshold pulmonary vascular resistance
Pulmonary vascular resistance (PVR) >3 Wood units is a criterion of the haemodynamic definition of pulmonary arterial hypertension (PAH). However, this cut-off is conservative and arbitrarily defined. Data is lacking on the natural history, response to therapy and survival of patients diagnosed with precapillary pulmonary hypertension (PH) with mild or borderline elevation of PVR.
In Australia, PAH therapy could be prescribed solely on mean pulmonary arterial pressure (PAP) and pulmonary arterial wedge pressure (PAWP) criteria. Using the Australian and New Zealand Pulmonary Hypertension Registry, we aimed to study ...
Source: European Respiratory Journal - July 8, 2020 Category: Respiratory Medicine Authors: Ratwatte, S., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D. S., Dwyer, N., Feenstra, J., Keating, D., Kotlyar, E., Lavender, M., Whitford, H., Whyte, K., Williams, T., Wrobel, J. P., Keogh, A., Lau, E. M., on behalf of the PHSANZ Re Tags: Pulmonary vascular disease Original Articles: Pulmonary hypertension Source Type: research
Vascular access specialist teams for device insertion and prevention of failure.
CONCLUSIONS: This systematic review failed to locate relevant published RCTs to support or refute the assertion that vascular access specialist teams are superior to the generalist model. A vascular access specialist team has advanced knowledge with regard to insertion techniques, clinical care, and management of vascular access devices, whereas a generalist model comprises nurses, doctors, or other designated healthcare professionals in the healthcare facility who may have less advanced insertion techniques and who care for vascular access devices amongst other competing clinical tasks. However, this conclusion may change...
Source: Cochrane Database of Systematic Reviews - March 20, 2018 Category: General Medicine Authors: Carr PJ, Higgins NS, Cooke ML, Mihala G, Rickard CM Tags: Cochrane Database Syst Rev Source Type: research
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
CONCLUSIONS: Results of this review show the effectiveness of anti-VEGF agents (pegaptanib, ranibizumab, and bevacizumab) in terms of maintaining visual acuity; studies show that ranibizumab and bevacizumab improved visual acuity in some eyes that received these agents and were equally effective. Available information on the adverse effects of each medication does not suggest a higher incidence of potentially vision-threatening complications with intravitreous injection of anti-VEGF agents compared with control interventions; however, clinical trial sample sizes were not sufficient to estimate differences in rare safety ou...
Source: Cochrane Database of Systematic Reviews - March 3, 2019 Category: General Medicine Authors: Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS Tags: Cochrane Database Syst Rev Source Type: research
